The European Commission’s Implementation Dialogue on EU Funding and Regional Competitiveness, held in September 2025, brought together a diverse group of participants from across Europe to exchange views on how EU funds can better support innovation, competitiveness, and regional development.
The European Commission has allocated €14 billion to nine Member States under the Support to mitigate Unemployment Risks in an Emergency (SURE) programme.
AstraZeneca CEO Pascal Soriot spoke to Antonello Guerrera about the ongoing vaccine feud - with the Commission receiving 60% less than expected, raising tense questions about why.
The BlueInvest fund today allocated the first of an available €75 million to two projects working against food insecurity - announcing the names at a BlueInvest Day event.
In response to the AstraZeneca feud, EU officials are creating a "transparency mechanism" for vaccine exports - which would indirectly hold companies accountable for fulfilling their agreed contracts.
EU leaders are investigating why AstraZeneca are not following through with the pre-agreed number of vaccines for the Member States - taking a 60% cut to the expected amount.
The projects will happen in 14 Member States and the United Kingdom, with 36 million in funding to get COVID-19 plasma to patients - boosting their immune response to the virus.
